Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Bladder and Renal Cancer: Scandinavian Cohort Study. Ueda P, Svanstrom H, Hviid A, Eliasson B, et al. Diabetes Care 2022;45:e93-e96.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ueda P, Svanstrom H, Hviid A, Eliasson B, et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Bladder and Renal Cancer: Scandinavian Cohort Study. Diabetes Care 2022;45:e93-e96.
PMID: 35312767